IPO Profile: TRACON Pharmaceuticals IncThe drug developer, backed by NEA, Jafco and others, raised $36 million in its IPOByStaff Writer1 February 2015•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.Managers
